Trial intelligence / Profile preview

Boostrix and Gardasil with MenACWY in Healthy Adolescents

NCT01424644Phase 4Completed

Sponsor
Novartis
Start
Sep 2011
Primary completion
Dec 2012
Modality
Vaccines & Immunotherapeutics
Countries
2
01

Overview

A Phase 4 trial of Meningococcal A, C, Y and W-135 conjugate vaccine in meningococcal meningitis, Tetanus, diphtheria, pertussis, human papillomavirus infection, sponsored by Novartis. Started Sep 2011; status: completed.

02

Drugs

Meningococcal A, C, Y and W-135 conjugate vaccine
03

Conditions

meningococcal meningitisTetanusdiphtheriapertussishuman papillomavirus infection

Beyond the preview

Go deeper on NCT01424644.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01424644.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call